2013
Web results:
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and serves as CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza to provide the general public access to their genetic information.
Anne Wojcicki is the cofounder and CEO of 23andMe, a pioneering direct-to-consumer genetics testing firm based in South San Francisco, California. In June 2021, 23andMe went public in a SPAC...
Anne Wojcicki, (born July 28, 1973, San Mateo county, California), American entrepreneur and cofounder and chief executive officer of the personal genetics company 23andMe. Wojcicki received a B.S. degree (1996) in biology from Yale University .
Anne Wojcicki co-founded the genetic testing company 23andMe in 2006, and took the company public in June 2021 through a merger with a special purpose acquisition company. 23andMe currently has a...
View Anne Wojcicki’s profile on LinkedIn, the world’s largest professional community. Anne has 5 jobs listed on their profile. See the complete profile on LinkedIn and discover Anne’s ...
Anne Wojcicki went from being an ignored wife of a billionaire to a billionaire in her own right. She invented revolutionary technology where people can discover their ancestry and potential genetic health risks without leaving home. Now as CEO of 23andMe, she’s used her wealth to help other women develop their groundbreaking ideas with funding.
May 20, 2021 Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006.
Less than six months later, Wojcicki’s net worth has fallen by more than $450 million, with her 23andMe stake valued at just over $860 million based on Wednesday’s opening price of $8.68 per ...
Anne Wojcicki, Chief Executive Officer of 23andMe, photographed for Forbes by Aaron Kotowski in June 2019. Aaron Kotowski/The Forbes Collection The cofounder and CEO of 23andMe spoke to...
As a featured speaker in the Stanford Biodesign From the Innovator’s Workbench series, Wojcicki told the story of her groundbreaking company, 23andMe —from its origin through her decision to take the company public with a special-purpose acquisition company (SPAC) that raised nearly $600 million.